Present and future roles of bevacizumab in breast cancer

被引：2
作者：
Cortes-Funes, H. [1 ]
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
来源：
BREAST CANCER RESEARCH | 2007年 / 9卷 / 01期
关键词：
Vascular Endothelial Growth Factor; Overall Survival; Paclitaxel; Bevacizumab; Docetaxel;
D O I：
10.1186/bcr1705
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab
    Polyzos, Aris
    Kalbakis, Kostas
    Kentepozidis, Nikolaos
    Giassas, Stylianos
    Kalykaki, Antonia
    Vardakis, Nikolaos
    Bozionelou, Vasiliki
    Saloustros, Emmanouel
    Kontopodis, Emmanouel
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 217 - 223
  • [42] Bevacizumab Treatment for Advanced Breast Cancer
    Alvarez, Ricardo H.
    Guarneri, Valentina
    Icli, Fikri
    Johnston, Stephen
    Khayat, David
    Loibl, Sibylle
    Martin, Miguel
    Zielinski, Christoph
    Conte, PierFranco
    Hortobagyi, Gabriel N.
    ONCOLOGIST, 2011, 16 (12) : 1684 - 1697
  • [43] Bevacizumab in advanced cervical cancer
    P. J. Vlachostergios
    C. N. Papandreou
    Clinical and Translational Oncology, 2014, 16 : 935 - 935
  • [44] Bevacizumab in advanced endometrial cancer
    Rubinstein, Maria M.
    Dickinson, Shannan
    Narayan, Priyanka
    Zhou, Qin
    Iasonos, Alexia
    Ma, Weining
    Lakhman, Yulia
    Makker, Vicky
    GYNECOLOGIC ONCOLOGY, 2021, 161 (03) : 720 - 726
  • [45] Effect of bevacizumab combined with docetaxel in the treatment of HER-2-negative recurrent metastatic breast cancer
    Wu, Ming
    Gong, Jianming
    Yu, Wei
    Geng, Jinhong
    Zeng, Linwen
    Kong, Xiangdong
    JOURNAL OF BUON, 2020, 25 (04): : 1814 - 1820
  • [46] Bevacizumab in colorectal cancer: current and future directions
    Yeung, Yvonne
    Tebbutt, Niall C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (10) : 1263 - 1273
  • [47] Prognostic Impact of Smoking on Bevacizumab Combination Chemotherapy for Advanced Breast Cancer
    Takada, Koji
    Kashiwagi, Shinichiro
    Iimori, Nozomi
    Kouhashi, Rika
    Yabumoto, Akimichi
    Goto, Wataru
    Asano, Yuka
    Tauchi, Yukie
    Ogisawa, Kana
    Morisaki, Tamami
    Shibutani, Masatsune
    Tanaka, Hiroaki
    Maeda, Kiyoshi
    ANTICANCER RESEARCH, 2023, 43 (02) : 849 - 856
  • [48] Bevacizumab in advanced breast cancer: an opportunity as second-line therapy?
    Petrelli, Fausto
    Barni, Sandro
    MEDICAL ONCOLOGY, 2012, 29 (01) : 1 - 4
  • [49] Bevacizumab in First-Line Treatment of Metastatic Breast CancerA Viewpoint by Xavier Pivot
    Xavier Pivot
    Drugs, 2007, 67 : 1800 - 1801
  • [50] Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
    von Minckwitz, Gunter
    Eidtmann, Holger
    Rezai, Mahdi
    Fasching, Peter A.
    Tesch, Hans
    Eggemann, Holm
    Schrader, Iris
    Kittel, Kornelia
    Hanusch, Claus
    Kreienberg, Rolf
    Solbach, Christine
    Gerber, Bernd
    Jackisch, Christian
    Kunz, Georg
    Blohmer, Jens-Uwe
    Huober, Jens
    Hauschild, Maik
    Fehm, Tanja
    Mueller, Berit Maria
    Denkert, Carsten
    Loibl, Sibylle
    Nekljudova, Valentina
    Untch, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) : 299 - 309
12345